Puma Biotechnology (PBYI) PT Raised to $88 at RBC Capital
Tweet Send to a Friend
RBC Capital raised its price target on Puma Biotechnology (NASDAQ: PBYI) to $88.00 (from $60.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
